Skip to main content
Log in

The Enthesopathy of XLH Is a Mechanical Adaptation to Osteomalacia: Biomechanical Evidence from Hyp Mice

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

A major comorbidity of X-linked hypophosphatemia (XLH) is fibrocartilaginous tendinous insertion site mineralization resulting in painful enthesophytes that contribute to the adult clinical picture and significantly impact physical function. Enthesophytes in Hyp mice, a murine model of XLH are the result of a hyperplastic expansion of resident alkaline phosphatase, Sox9-positive mineralizing fibrochondrocytes. Here, we hypothesized hyperplasia as a compensatory physical adaptation to aberrant mechanical stresses at the level of the entheses interface inserting into pathologically soft bone. To test this hypothesis, we examined the Achilles insertion of the triceps surae developed under normal and impaired loading conditions in Hyp and WT mice. Tensile stiffness, ultimate strength, and maximum strain were measured and compared. Biomechanical testing revealed that under normal loading conditions, despite inserting into a soft bone matrix, both the enthesophyte development (9 weeks) and progression (6–8 months) of Hyp mice were equivalent to the mechanical properties of WT mice. Unloading the insertion during development significantly reduced alkaline phosphatase, Sox9-positive fibrochondrocytes. In WT mice, this correlated with a decrease in stiffness and ultimate strength relative to the control limb, confirming the critical role of mechanical loading in the development of the enthesis. Most significantly, in response to unloading, maximum strain was increased in tensile tests only in the setting of subchondral osteomalacia of Hyp mice. These data suggest that mineralizing fibrochondrocyte expansion in XLH occurs as a compensatory adaptation to the soft bone matrix.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK (2009) Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 160:491–497

    Article  CAS  Google Scholar 

  2. Carpenter TO (1997) New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. Pediatr Clin North Am 44:443–466

    Article  CAS  Google Scholar 

  3. Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, Yamauchi M, Sugimoto T, Minagawa M, Michigami T, Nagai M, Matsumoto T (2015) Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J 62:811–816

    Article  CAS  Google Scholar 

  4. Macica CM (2017) Overview of phosphorus-wasting diseases and need for phosphorus supplements. In: Uribarri J, Calvo MS (eds) Dietary phosphorus: health, nutrition, and regulatory aspects. CRC Press, Boca Raton

    Google Scholar 

  5. Francis F, Hennig S, Korn B, Reinhardt R et al (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets The HYP consortium. Nat Genet 11:130–136

    Article  CAS  Google Scholar 

  6. Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278:37419–37426

    Article  CAS  Google Scholar 

  7. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435

    Article  CAS  Google Scholar 

  8. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957–4960

    Article  CAS  Google Scholar 

  9. Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP (1989) X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine 68:336–352

    Article  CAS  Google Scholar 

  10. Hughes M, Macica C, Meriano C, Doyle M (2020) Giving credence to the experience of X-linked hypophosphatemia in adulthood: an interprofessional mixed-methods study. J Patient Cent Res Rev 7:176–188

    Article  Google Scholar 

  11. Steele A, Gonzalez R, Garbalosa JC, Steigbigel K, Grgurich T, Parisi EJ, Feinn RS, Tommasini SM, Macica CM (2020) Osteoarthritis, osteophytes, and enthesophytes affect biomechanical function in adults with X-linked hypophosphatemia. J Clin Endocrinol Metabol 105:e1798

    Article  Google Scholar 

  12. Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, Theodore-Oklota C, San Martin J (2019) The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocr Soc 3:1321–1334

    Article  Google Scholar 

  13. Faraji-Bellee CA, Cauliez A, Salmon B, Fogel O, Zhukouskaya V, Benoit A, Schinke T, Roux C, Linglart A, Miceli-Richard C, Chaussain C, Briot K, Bardet C (2020) Development of enthesopathies and joint structural damage in a murine model of X-linked hypophosphatemia. Front Cell Dev Biol 8:854

    Article  Google Scholar 

  14. Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM (2009) Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int 85:235–246

    Article  CAS  Google Scholar 

  15. Karaplis AC, Bai X, Falet JP, Macica CM (2012) Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice. Endocrinology 153:5906–5917

    Article  CAS  Google Scholar 

  16. Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, Briot K (2016) Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 174:325–333

    Article  CAS  Google Scholar 

  17. Herrou J, Picaud AS, Lassalle L, Pacot L, Chaussain C, Merzoug V, Herve A, Gadion M, Rothenbuhler A, Kamenicky P, Roux C, Linglart A, Duplan MB, Briot K (2022) Prevalence of enthesopathies in adults with X-linked hypophosphatemia: analysis of risk factors. J Clin Endocrinol Metab 107:e224–e235

    Article  Google Scholar 

  18. Liu ES, Martins JS, Zhang W, Demay MB (2018) Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets. Development. https://doi.org/10.1242/dev.163519

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liang G, Vanhouten J, Macica CM (2011) An atypical degenerative osteoarthropathy in Hyp mice is characterized by a loss in the mineralized zone of articular cartilage. Calcif Tissue Int 89:151–162

    Article  CAS  Google Scholar 

  20. Dyment NA, Breidenbach AP, Schwartz AG, Russell RP, Aschbacher-Smith L, Liu H, Hagiwara Y, Jiang R, Thomopoulos S, Butler DL, Rowe DW (2015) Gdf5 progenitors give rise to fibrocartilage cells that mineralize via hedgehog signaling to form the zonal enthesis. Dev Biol 405:96–107

    Article  CAS  Google Scholar 

  21. Thomopoulos S, Kim HM, Rothermich SY, Biederstadt C, Das R, Galatz LM (2007) Decreased muscle loading delays maturation of the tendon enthesis during postnatal development. J Orthop Res 25:1154–1163

    Article  Google Scholar 

  22. Mikic B, Schalet BJ, Clark RT, Gaschen V, Hunziker EB (2001) GDF-5 deficiency in mice alters the ultrastructure, mechanical properties and composition of the Achilles tendon. J Orthop Res 19:365–371

    Article  CAS  Google Scholar 

  23. Benjamin M, Kumai T, Milz S, Boszczyk BM, Boszczyk AA, Ralphs JR (2002) The skeletal attachment of tendons–tendon “entheses.” Comp Biochem Physiol 133:931–945

    Article  CAS  Google Scholar 

  24. Benjamin M, Ralphs JR (2000) The cell and developmental biology of tendons and ligaments. Int Rev Cytol 196:85–130

    Article  CAS  Google Scholar 

  25. Gao J, Messner K, Ralphs JR, Benjamin M (1996) An immunohistochemical study of enthesis development in the medial collateral ligament of the rat knee joint. Anat Embryol 194:399–406

    Article  CAS  Google Scholar 

  26. Benjamin M, Toumi H, Suzuki D, Hayashi K, McGonagle D (2009) Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 68:1003–1010

    Article  CAS  Google Scholar 

  27. Xu Y, Murrell GA (2008) The basic science of tendinopathy. Clin Orthop Relat Res 466:1528–1538

    Article  Google Scholar 

  28. Liu CF, Breidenbach A, Aschbacher-Smith L, Butler D, Wylie C (2013) A role for hedgehog signaling in the differentiation of the insertion site of the patellar tendon in the mouse. PLoS ONE 8:e65411

    Article  CAS  Google Scholar 

  29. Schwartz AG, Long F, Thomopoulos S (2015) Enthesis fibrocartilage cells originate from a population of Hedgehog-responsive cells modulated by the loading environment. Development (Cambridge, England) 142:196–206

    Article  CAS  Google Scholar 

  30. O’Conor CJ, Case N, Guilak F (2013) Mechanical regulation of chondrogenesis. Stem Cell Res Ther 4:61

    Article  Google Scholar 

  31. Macica CM, King HE, Wang M, McEachon CL, Skinner CW, Tommasini SM (2016) Novel anatomic adaptation of cortical bone to meet increased mineral demands of reproduction. Bone 85:59–69

    Article  Google Scholar 

  32. Amiel D, Woo SL, Harwood FL, Akeson WH (1982) The effect of immobilization on collagen turnover in connective tissue: a biochemical-biomechanical correlation. Acta Orthop Scand 53:325–332

    Article  Google Scholar 

  33. Bikle DD, Halloran BP (1999) The response of bone to unloading. J Bone Miner Metab 17:233–244

    Article  CAS  Google Scholar 

  34. Hayashibara T, Hiraga T, Sugita A, Wang L, Hata K, Ooshima T, Yoneda T (2007) Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions. J Bone Miner Res 22:1743–1751

    Article  CAS  Google Scholar 

  35. Connor J, Olear EA, Insogna KL, Katz L, Baker S, Kaur R, Simpson CA, Sterpka J, Dubrow R, Zhang JH, Carpenter TO (2015) Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease. J Clin Endocrinol Metab 100:3625–3632

    Article  CAS  Google Scholar 

  36. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res 26:1381–1388

    Article  Google Scholar 

  37. Glorieux FH, Bordier PJ, Marie P, Delvin EE, Travers R (1978) Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR). Adv Exp Med Biol 103:227–232

    Article  CAS  Google Scholar 

  38. Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Hogler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393:2416–2427

    Article  CAS  Google Scholar 

  39. Insogna KL, Rauch F, Kamenicky P, Ito N, Kubota T, Nakamura A, Zhang L, Mealiffe M, San Martin J, Portale AA (2019) Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial. J Bone Miner Res 34:2183–2191

    Article  CAS  Google Scholar 

  40. Cauliez A, Zhukouskaya VV, Hilliquin S, Sadoine J, Slimani L, Miceli-Richard C, Briot K, Linglart A, Chaussain C, Bardet C (2020) Impact of early conventional treatment on adult bone and joints in a murine model of X-linked hypophosphatemia. Front Cell Dev Biol 8:591417

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carolyn M. Macica.

Ethics declarations

Conflict of Interest

Carolyn M. Macica, Jack Luo and Steven M. Tommasini have no financial or conflicts of interests to disclose.

Ethical Approval

None.

Human and Animal Rights and Informed Consent

All animal procedures were approved by the Institutional Animal Care and Use Committee at Yale University and experiments conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals. No human studies were performed in the course of these experiments.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Macica, C.M., Luo, J. & Tommasini, S.M. The Enthesopathy of XLH Is a Mechanical Adaptation to Osteomalacia: Biomechanical Evidence from Hyp Mice. Calcif Tissue Int 111, 313–322 (2022). https://doi.org/10.1007/s00223-022-00989-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-022-00989-7

Keywords

Navigation